Denali Therapeutics Inc (DNLI) — Free Cash Flow Generation Index
Denali Therapeutics Inc (DNLI) has a Free Cash Flow Generation Index of 1.00x as of December 2020. Free cash flow of $512.72 Million represents 1% of operating cash flow ($513.91 Million). Explore Denali Therapeutics Inc (DNLI) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Denali Therapeutics Inc Free Cash Flow Generation Index (2018–2020)
Historical FCF Generation Index trend for Denali Therapeutics Inc across 2 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Denali Therapeutics Inc.
Annual Free Cash Flow Generation for Denali Therapeutics Inc (2018–2020)
Year-by-year Free Cash Flow Generation Index for Denali Therapeutics Inc. Check Denali Therapeutics Inc (DNLI) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.99x | $413.06 Million | $416.15 Million | $3.10 Million | ▲ +6.5% |
| 2018 | 0.93x | $46.72 Million | $50.12 Million | $3.39 Million | — |